In the not-to-distant future, RNA sequencing will become standard diagnostic testing at the initial evaluation of a patient with myeloma

October 2, 2015 Leave a comment 3,190 Views

Five years from now multiple myeloma will have a therapeutic backbone consisting entirely of combinations of novel agents, a leading myeloma researcher predicted. The combinations will involve immunomodulatory agents, proteasome inhibitors, and monoclonal antibodies. Stem-cell transplantation will retain a role ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: diagnostic testing

In the not-to-distant future, RNA sequencing will become standard diagnostic testing at the initial evaluation of a patient with myeloma

GiRAFR – gRNA detection and annotation in single-cell CRISPR screens

RNA sequencing reaveals novel intracellular signaling mechanisms that promote melanoma growth

AAV-Perturb-seq – adeno-associated virus (AAV)-mediated direct in vivo single-cell CRISPR screening

capTEs – Cas9-assisted profiling transposable elements expression sequencing

eSPET-seq – genome-wide probing of eukaryotic nascent RNA structure

DISCERN – deep single-cell expression reconstruction for improved cell clustering and cell subtype and state detection

Advancements in genome sequencing propel global RNA sequencing market growth to 2030